Related Experiment Video
Updated: Dec 17, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Mitral Annular Calcification In Stage 5 Chronic Kidney Disease On Dialysis Therapy
Abeera Mansur1, Sidra Saleem2, Haris Naveed3
1Doctors Hospital and Medical Center, Lahore, Pakistan.
Insights
Mitral annular calcification (MAC) is prevalent in 44% of hemodialysis patients and significantly correlates with ischemic heart disease (IHD). Longer dialysis duration increases MAC risk, supporting echocardiography for valvular calcification detection.
Area of Science:
- Cardiology
- Nephrology
- Valvular Heart Disease
Background:
- Mitral annular calcification (MAC) is a degenerative process and marker of cardiovascular disease.
- Prevalence increases with age, diabetes, and chronic kidney disease (CKD), reaching up to 40% in end-stage renal disease.
- CKD patients, particularly those on dialysis, represent a high-risk population for MAC.
Purpose of the Study:
- To determine the prevalence of MAC in patients with stage 5 CKD on hemodialysis.
- To identify patient characteristics associated with MAC in this population.
- To correlate MAC with cardiovascular outcomes and mortality.
Main Methods:
- Echocardiograms were performed on 84 hemodialysis patients.
- Statistical analysis was used to assess the association between MAC and patient characteristics.
- Patient data included demographics, comorbidities, dialysis duration, and laboratory values.
Main Results:
- MAC was present in 44% of the 84 hemodialysis patients.
- MAC significantly correlated with ischemic heart disease (IHD) (OR=6.42, p=0.006).
- Dialysis duration exceeding 36 months (OR=3.32, p=0.019) and IHD were significant risk factors for MAC.
Conclusions:
- Mitral annular calcification is common in hemodialysis patients.
- MAC is significantly associated with IHD in this cohort.
- Echocardiography is recommended for detecting valvular calcification in CKD patients, aligning with KDIGO guidelines.
Background:
Mitral Annular Calcification (MAC) is a degenerative process involving the mitral valve and is a marker of advanced cardiovascular disease. Prevalence in the general population is upto 10% and increases in advanced age, diabetes mellitus, chronic kidney disease (CKD), end stage renal disease (upto 40%) and mitral valve prolapse.The aims of this study were to assess the prevalence of MAC in CKD5D patients and correlate with patients' characteristics.
Methods:
Echocardiograms were obtained in 84 hemodialysis patients. Association of MAC with various patient characteristics was studied. Data was analysed using SPSS-22.
Results:
The mean age of the patients was 63.38±12.3 years and 48 (57%) were males. Sixty-eight patients (81%) had DM and 79 (94%) had hypertension. MAC was present in 37 out of 84 (44%) patients. Sixty-four (72%) had IHD. The presence of MAC correlated significantly with IHD (Odds Ratio 6.42, p=0.006). Mean follow up of the patients was 30.30±29.22 months and 37 (44%) suffered mortality during this period. Patients on dialysis for longer than 36 months had an elevated risk of developing MAC (OR=3.32, p=0.019). Patients with the following risk factors: serum PO4 greater than 5.5 (OR=2.03), DM (OR=1.95), HTN (OR=3.35), Age >60 (OR=1.83), AFIB (OR=1.28); had an observable increase in incidence of MAC with time but they weren't statistically significant.
Conclusions:
Mitral Annular Calcification is common in hemodialysis patients and correlates significantly with IHD. Our findings support the recommendation by KDIGO 2017 guidelines on Mineral and Bone Disease on the use of echocardiography for the detection of valvular calcification.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Mitral Stenosis II: Clinical features and Diagnostic Tests
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Mitral Stenosis I: Introduction

